NCCN Guidelines Version 3.2022
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Histologic Transformation (Richter's) and Progression
Chronic Lymphocytic Leukemia-English Version 2022
Chronic Lymphocytic Leukemia-Arabic Version 2021
Continuing Education
Guideline Updates and Real-World Experiences in CLL: State-of-the-Art Evidence and Next Questions
Case 3: Relapsed CLL/SLL without del(17p)/TP53 mutation in a patient ≥65 years
NCCN Guidelines® Insights - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022
Optimizing Treatment Approaches for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Translations
Chinese Version 1.2022
French Version 2.2017
German Version 2.2017
Italian Version 2.2017
Portuguese Version 1.2022
Spanish Version 2.2022
Adaptations
English (Middle East & North Africa) Version 2.2017
Harmonized
English (Africa) Version 3.2022